Development and validation of the Vietnamese smell identification test
- PMID: 37413956
- DOI: 10.1016/j.parkreldis.2023.105494
Development and validation of the Vietnamese smell identification test
Abstract
Background: Correct olfactory identification requires familiarity with the odor stimuli and is culturally dependent. Existing smell identification tests (SIT) are not culturally specific and may not be reliable in detecting hyposmia in all populations. This study aimed to develop a smell identification test suitable for Vietnamese patients (VSIT).
Methods: The study included 4 phases: 1) survey-based evaluation of the familiarity of 68 odors to identify 18 odors for subsequent testing (N = 1050); 2) smell identification test of 18 odors in healthy patients (N = 50) to determine which 12 should be included in the VSIT; 3) comparison of VSIT scores on 12 odors in patients with hyposmia (N = 60; Brief smell identification test (BSIT) score <8 and those with normosmia (N = 120; BSIT score ≥8) to establish the validity of the newly developed test; and 4) retest of the VSIT in 60 normosmic patients from phase 3 (N = 60) to determine test-retest reliability.
Results: As expected, the mean (SD) VSIT score was significantly higher in the healthy participants than in the hyposmic patients [10.28 (1.34) vs 4.57 (1.76); P < 0.001]. Using a cut-off score at 8, the sensitivity and specificity of the instrument in detecting hyposmia were 93.3% and 97.5% respectively. The test-retest reliability using the intra-class correlation coefficient was at 0.72 (P < 0.001).
Conclusion: The Vietnamese Smell Identification Test (VSIT) demonstrated favorable validity and reliability and will allow for assessment of olfactory function in Vietnamese patients.
Keywords: Hyposmia; Reliability; Smell identification test; Validity.
Copyright © 2023. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of competing interest Tai Ngoc Tran: has received consultation and/or honoraria/lecture fees from Boehringer-Ingelheim, Ipsen Pharmaceuticals, and Medtronic, and research funding from University Medical Center, University of Medicine and Pharmacy at Ho Chi Minh City. Daniel Truong: has received consultation and/or honoraria/lecture fees from Neurocrine Inc., Teva Pharmaceutical Inc., He received research funding from AbbVie, Acadia Cynapsus, Daiichi Sankyo Pharma, Intec, Ipsen, Kyowa, Merz, National Institute of Neurological Disorders and Stroke, Neurocrine, Neuroderm Ltd, Sunovion, Acorda Sage, Takeda, Cerevel Therapeutics, UCB Pharma, Pharmather, Inc., Teva, Aeon Biopharma, Bukwang Pharmaceuticals, Lundbeck Pharmaceuticals.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials